SMA Research Platform

Evidence graph for Spinal Muscular Atrophy

Biology-first target discovery
Christian Fischer / Bryzant Labs
14,766Targets
453Trials
84Drugs
7Datasets
6,987Sources
64,683Claims
72,052Evidence
29,649Hypotheses
TARGETgeneHomo sapiens

MTNR1AMelatonin receptor 1A (MT1)

Description

GPCR melatonin receptor — melatonin rescues SMA Smn2B/- mouse + C. elegans (O39 Bowerman Budapest 2026).

Linked hypotheses (12)

  • Off-target candidate: **risdiplam** → MTNR1A (iPTM=0.927)
    mechanismconf 93%
  • risdiplam off-target binding to MTNR1A
    repurposingconf 93%
  • Off-target candidate: **pyridostigmine** → MTNR1A (iPTM=0.932)
    mechanismconf 93%
  • Off-target candidate: **risdiplam** → MTNR1A (iPTM=0.928)
    mechanismconf 93%
  • Off-target candidate: **risdiplam** → MTNR1A (iPTM=0.931)
    mechanismconf 93%
  • Off-target candidate: **riluzole** → MTNR1A (iPTM=0.891)
    mechanismconf 89%
  • riluzole off-target binding to MTNR1A
    repurposingconf 89%
  • Off-target candidate: **risdiplam** → MTNR1A (iPTM=0.892)
    mechanismconf 89%
  • Off-target candidate: **fasudil** → MTNR1A (iPTM=0.877)
    mechanismconf 88%
  • Off-target candidate: **risdiplam** → MTNR1A (iPTM=0.867)
    mechanismconf 87%
  • Off-target candidate: **riluzole** → MTNR1A (iPTM=0.858)
    mechanismconf 86%
  • Off-target candidate: **4AP_ampyra** → MTNR1A (iPTM=0.814)
    mechanismconf 81%

Top compound hits (0)

No ranked compounds yet for MTNR1A.

Linked claims (0)

No claims linked.

Login → Command Center